Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

72 insider filings · Latest: Sep 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 3, 2026Jun 3 7:59 PMShields Matthew
Proposed Sale
16,195$32.87$532.3K—

View →

May 14, 2026May 18 8:02 PMEvan LippmanEVP, Business Development
Sale
41,658$35.58$1.5M44,191(D)

View →

May 14, 2026May 18 8:00 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
153,251$35.61$5.5M172,184(D)

View →

May 14, 2026May 14 8:02 PMLippman Evan
Proposed Sale
41,658$35.58$1.5M—

View →

May 14, 2026May 14 7:59 PMKalif Eliyahu Sharon
Proposed Sale
153,251$35.61$5.5M—

View →

May 6, 2026May 7 8:03 PMAmir WeissChief Accounting Officer
Sale
10,679$36.00$384.4K20,016(D)

View →

May 5, 2026May 7 8:01 PMRichard DaniellEVP, Europe Commercial
Sale
30,000$35.40$1.1M55,755(D)

View →

May 5, 2026May 5 8:00 PMDaniell Richard
Proposed Sale
30,000$35.40$1.1M—

View →

May 1, 2026May 4 8:02 PMMark SabagSee "Remarks"
Sale
144,180$34.99$5.0M80,760(D)

View →

Apr 30, 2026May 4 8:00 PMChristine FoxEVP, U.S. Commercial
Sale
21,258$35.31$750.6K63,647(D)

View →

May 1, 2026May 4 12:12 PMSabag Mark
Proposed Sale
144,180$34.99$5.0M—

View →

Apr 30, 2026Apr 30 8:40 PMChristine Fox
Proposed Sale
21,258$35.31$750.6K—

View →

Mar 17, 2026Mar 19 8:01 PMMark SabagSee "Remarks"
Sale
62,102$30.14$1.9M224,940(D)

View →

Mar 17, 2026Mar 17 8:15 PMSabag Mark
Proposed Sale
62,102$30.14$1.9M—

View →

Mar 5, 2026Mar 9 8:18 PMRichard D FrancisPresident and CEO
Sale
20,025$31.67$634.2K1,170,639(D)

View →

Mar 5, 2026Mar 9 8:16 PMChristine FoxEVP, U.S. Commercial
Sale
7,924$31.67$250.9K84,905(D)

View →

Mar 5, 2026Mar 9 8:14 PMEric A HughesSee "Remarks"
Sale
9,533$31.67$301.9K107,711(D)

View →

Mar 5, 2026Mar 9 8:12 PMRichard DaniellEVP, Europe Commercial
Sale
17,295$31.67$547.7K85,755(D)

View →

Mar 5, 2026Mar 9 8:10 PMPlacid JoverSee "Remarks"
Sale
14,150$31.67$448.1K6,774(D)

View →

Mar 5, 2026Mar 9 8:09 PMBrian SavageInterim Chief Legal Officer
Sale
1,127$31.67$35.7K10,914(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 18, 2026Sep 22 9:01 PMBrian SavageInterim Chief Legal Officer
Option Exercise
4,503$34.700(D)

View →

Aug 21, 2026Aug 25 8:05 PMAmir WeissChief Accounting Officer
Option Exercise
2,500$19.167,502(D)

View →

Aug 3, 2026Aug 5 8:04 PMPlacid JoverSee "Remarks"
Option Exercise
12,827—25,657(D)

View →

Aug 3, 2026Aug 5 8:02 PMEric A HughesSee "Remarks"
Option Exercise
52,744—0(D)

View →

Jun 5, 2026Jun 8 8:07 PMBARER SOL JDirector
Option Exercise
21,739—0(D)

View →

Jun 5, 2026Jun 8 8:06 PMChen LichtensteinDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:06 PMRosemary A CraneDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:05 PMAmir ElsteinDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:04 PMGerald M LiebermanDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:04 PMPerry NisenDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:03 PMRonit Satchi-FainaroDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:03 PMTal Zvi ZaksDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:02 PMRoberto MignoneDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:01 PMRichard D FrancisPresident and CEO
Option Exercise
13,043—39,130(D)

View →

Jun 3, 2026Jun 4 8:00 PMMatthew ShieldsEVP, Global Operations
Option Exercise
16,195—32,392(D)

View →

May 28, 2026Jun 1 8:16 PMTal Zvi ZaksDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:15 PMRonit Satchi-FainaroDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:13 PMPerry NisenDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:11 PMGerald M LiebermanDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:09 PMAmir ElsteinDirector
Grant/Award
7,242—7,242(D)

View →

Page 1 of 4

Next →